Controlled Drugs and Substances Act (S.C. 1996, c. 19)
Full Document:
- HTMLFull Document: Controlled Drugs and Substances Act (Accessibility Buttons available) |
- XMLFull Document: Controlled Drugs and Substances Act [388 KB] |
- PDFFull Document: Controlled Drugs and Substances Act [710 KB]
Act current to 2025-03-03 and last amended on 2024-09-03. Previous Versions
SCHEDULE VI(Sections 2, 6, 55 and 60)
PART 1
Class A PrecursorsFootnote 1
- 1Acetic anhydride
- 2N-Acetylanthranilic acid (2-acetamidobenzoic acid) and its salts
- 3Anthranilic acid (2-aminobenzoic acid) and its salts
- 4Ephedrine (erythro-2-(methylamino)-1-phenylpropan-1-ol), its salts and any plant containing ephedrine or any of its salts
- 5Ergometrine (9,10-didehydro-N-(2-hydroxy-1-methylethyl)-6-methylergoline-8-carboxamide) and its salts
- 6Ergotamine (12′-hydroxy-2′-methyl-5′-(phenylmethyl)ergotaman-3′,6′,18-trione) and its salts
- 7Isosafrole (5-(1-propenyl)-1,3-benzodioxole)
- 8Lysergic acid (9,10-didehydro-6-methylergoline-8-carboxylic acid) and its salts
- 93,4-Methylenedioxyphenyl-2-propanone (1-(1,3-benzodioxole)-2-propanone), its derivatives and analogues and salts of derivatives and analogues, including:
- (1)methyl 3-(1,3 benzodioxol-5-yl)-2-methyloxirane-2-carboxylate (MMDMG)
- 10Norephedrine (Phenylpropanolamine) and its salts
- 111-Phenyl-2-propanone, its derivatives and analogues and salts of derivatives and analogues, including:
- (1)methyl 2-methyl-3-phenyloxirane-2-carboxylate (BMK methyl glycidate)
- (2)3-oxo-2-phenylbutanamide (α- phenylacetoacetamide-APAA)
- 12Phenylacetic acid and its salts
- 13Piperidine and its salts
- 14Piperonal (1,3-benzodioxole-5-carboxaldehyde)
- 15Potassium permanganate
- 16Pseudoephedrine (threo-2-(methylamino)-1-phenylpropan-1-ol), its salts and any plant containing pseudoephedrine or any of its salts
- 17Safrole (5-(2-propenyl)-1,3-benzodioxole) and any essential oil containing more than 4% safrole
- 18Gamma-butyrolactone (dihydro-2(3H)-furanone)
- 191,4-butanediol
- 20Red Phosphorus
- 21White Phosphorus
- 22Hypophosphorous acid, its salts and derivatives
- 23Hydriodic acid
- 24Alpha-phenylacetoacetonitrile and its salts, isomers and salts of isomers
- 25Propionyl chloride
- 261-Phenethyl-4-piperidone and its salts
- 274-Piperidone (piperidin-4-one), its salts, derivatives and analogues and salts of derivatives and analogues, including:
- (1)1-boc-4-piperidone (tert-butyl 4-oxopiperidine-1-carboxylate)
- (2)3-methyl-4-piperidone (3-methylpiperidin-4-one)
- (3)1-benzyl-4-piperidone (1-benzylpiperidin-4-one)
- 28Norfentanyl (N-phenyl-N-piperidin-4-ylpropanamide), its salts, derivatives and analogues and salts of derivatives and analogues
- 291-Phenethylpiperidin-4-ylidenephenylamine and its salts
- 30N-Phenyl-4-piperidinamine (N-phenylpiperidin-4-amine), its salts, derivatives and analogues and salts of derivatives and analogues, including:
- (1)4-anilino-1-boc-piperidine (tert-butyl 4-(phenylamino)piperidine-1-carboxylate)
- (2)4-fluoro anilino-1-boc-piperidine (tert-butyl 4-((4-fluorophenyl)amino)piperidine-1-carboxylate)
- (3)N-(4-fluorophenyl)-4-piperidinamine (N-(4-fluorophenyl)piperidin-4-amine)
- (4)4-bromo anilino-1-boc-piperidine (tert-butyl 4-((4-bromophenyl)amino)piperidine-1-carboxylate)
- 31N1,N1,N2-trimethylcyclohexane-1,2-diamine and its salts
- 32Benzylfentanyl (N-(1-benzylpiperidin-4-yl)-N-phenylpropionamide), its salts, derivatives and analogues and salts of derivatives and analogues
Return to footnote 1Each Class A precursor includes synthetic and natural forms.
PART 2
Class B PrecursorsFootnote 1
- 1Acetone
- 2Ethyl ether
- 3Hydrochloric acid
- 4Methyl ethyl ketone
- 5Sulphuric acid
- 6Toluene
Return to footnote 1Each Class B precursor includes synthetic forms.
PART 3
Preparations and Mixtures
- 1Any preparation or mixture that contains a precursor set out in Part 1, except items 20 to 23, or in Part 2.
- 1996, c. 19, Sch. VI
- SOR/2002-361, s. 2
- 2005-364, ss. 1, 2, 3(F), 4
- SOR/2016-13, 295
- SOR/2017-277, s. 2
- SOR/2019-121, s. 2
- SOR/2019-121, s. 3
- SOR/2019-121, s. 4
- SOR/2019-121, s. 5
- SOR/2023-103, s. 1
- SOR/2023-248, s. 1(F)
- SOR/2024-98, s. 2
- Date modified: